SANOFI GENZYME - INDUSTRY SUPPORTED SYMPOSIUM

![]() Supported by Sanofi Genzyme Saturday, March 24, 2018
12:10-13:10 |
|||
Demand more from MS therapy: Can the new endpoints replace the traditional? |
|||
Chair: Prof Krzysztof Selmaj, Poland
|
|||
Faculty: Prof Jan Lycke, Sweden, Prof Nikolaos Grigoriadis, Greece
|
|||
|